Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1527473-33-1N#Cc1cccc(-c2c[nH]c3ncnc(N4CCOCC4)c23)c1BHTWDJBVZQBRKP-UHFFFAOYSA-NPF-06447475 is an organic molecular entity. It has a role as an EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor.
1527473-33-1Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
VerwendenPF 06447475 is a highly potent LRRK2 kinase inhibitor. Highly selective, and mobile, it is used in the treatment of Parkinson’s disease which has been linked to Leucine rich repeat kinase 2 (LRRK2) enzymes.
CHEMBL3393348CHEBI:233295